Valuing Innovative Drugs Based On Their Cost Of Manufacturing Will Prolong The Covid-19 Pandemic - News Summed Up

Valuing Innovative Drugs Based On Their Cost Of Manufacturing Will Prolong The Covid-19 Pandemic


gettyThe value of innovative medicines has absolutely nothing to do with its cost of production. A dangerous tension exists because once an innovative drug is discovered, manufacturing the compound is relatively easy. But, the value of innovative drugs is not reflected in the costs of physically manufacturing the products. The same is true for innovative drugs, particularly the drugs that could be effective treatments for Covid-19. It is a myth that the value of innovative medicines is based on their cost of production.


Source: Forbes August 14, 2020 14:48 UTC



Loading...
Loading...
  

Loading...

                           
/* -------------------------- overlay advertisemnt -------------------------- */